Health / Health News

    Research on new, rapid screening test identifies potential therapies against drug-resistant bacteria

    Researchers have created a new way to identify drugs and drug combinations that may potentially be useful in combating infections that are resistant to many different antibiotics. They developed an assay (test) to rapidly screen thousands of drugs to determine how effective they were against a variety of types of resistant bacteria.



    Colorized scanning-electron micrograph showing carbapenem-resistant Klebsiella pneumoniae interacting with a human white blood cell.


    The screening method provides a potential new approach to repurpose known drugs and compounds to potentially help deal with powerful, hospital-borne infections, as well as emerging infectious diseases.

    The researchers used the test to screen approximately 4,000 approved drugs and other biologically active compounds, identifying 25 that suppressed the growth of two drug-resistant strains of Klebsiella pneumoniae that have become resistant to most major types of antibiotics.

    The researchers also used the screening test to gauge the effectiveness of combinations of drugs against antibiotic-resistant bacteria in this study. They found three different three-drug combinations that were effective against 10 common strains of multi-drug-resistant bacteria. (NIH)

    NOVEMBER 23, 2016



    YOU MAY ALSO LIKE

    The ever-changing “head” of an influenza virus protein has an unexpected Achilles heel, report scientists.
    Scientists have found a connection between bacteria in the gut and antitumor immune responses in the liver.
    Researchers developed a noninvasive method to detect both early- and late-stage pancreatic cancer. If the findings are confirmed in a larger group, they could lead to routine tests that catch pancreatic tumors early and boost survival rates.
    Researchers have detected evidence suggesting Alzheimer's in older patients who had no symptoms of the disease by using technology similar to what is found in many eye doctors' offices.
    Researchers with the National Human Genome Research Institute have collaborated with physicians and medical geneticists around the world to create the Atlas of Human Malformation Syndromes in Diverse Populations.
    Among people with early-stage multiple sclerosis (MS), those with higher blood levels of vitamin D had better outcomes during 5 years of follow-up. Identifying and correcting vitamin D insufficiency could aid in the early treatment of MS.

    © 1991-2023 The Titi Tudorancea Bulletin | Titi Tudorancea® is a Registered Trademark | Terms of use and privacy policy
    Contact